Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2006 3
2007 1
2008 5
2009 7
2010 6
2011 4
2012 8
2013 8
2014 10
2015 11
2016 9
2017 12
2018 14
2019 8
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Results by year
Filters applied: . Clear all
Page 1
Co-Signaling Molecules in Maternal-Fetal Immunity.
Xu YY, Wang SC, Li DJ, Du MR. Xu YY, et al. Trends Mol Med. 2017 Jan;23(1):46-58. doi: 10.1016/j.molmed.2016.11.001. Epub 2016 Dec 1. Trends Mol Med. 2017. PMID: 27914866 Review.
The landscape of immune microenvironment in lung adenocarcinoma and squamous cell carcinoma based on PD-L1 expression and tumor-infiltrating lymphocytes.
Chen L, Cao MF, Zhang X, Dang WQ, Xiao JF, Liu Q, Tan YH, Tan YY, Xu YY, Xu SL, Yao XH, Cui YH, Zhang X, Bian XW. Chen L, et al. Among authors: Xu YY, Xu SL. Cancer Med. 2019 Dec;8(17):7207-7218. doi: 10.1002/cam4.2580. Epub 2019 Oct 11. Cancer Med. 2019. PMID: 31605439 Free PMC article.
[Molecular Markers of Prognosis in Myelodysplastic Syndromes--Review].
Xu YY, Yu L. Xu YY, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Feb;24(1):285-9. doi: 10.7534/j.issn.1009-2137.2016.01.055. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 26913438 Review. Chinese.
Development of targeted therapies in treatment of glioblastoma.
Xu YY, Gao P, Sun Y, Duan YR. Xu YY, et al. Cancer Biol Med. 2015 Sep;12(3):223-37. doi: 10.7497/j.issn.2095-3941.2015.0020. Cancer Biol Med. 2015. PMID: 26487967 Free PMC article. Review.
106 results
Jump to page
Feedback